Why rare disease clinical trials are rare in themselves

We're immensely proud to have achieved a Platinum accreditation from Investors in People, placing us among the top 2% of organisations assessed globally.

Discover our predicted 2025 healthcare and Pharma trends: AI in trials, diversity mandates, mental health innovations, hybrid methodologies, immunotherapy support, and direct-to-patient recruitment.